AGI-6780 --- Mutant IDH2 Inhibitor

Bioss Antibodies

AGI-6780 --- Mutant IDH2 Inhibitor [1432660-47-3]

16

Research Use Only

98.0

AGI-6780 is a potent and selective IDH2 inhibitor. AGI-6780 inhibits the tumor-associated mutant IDH2/R140Q. Treatment with AGI-6780 induced differentiation of TF-1 erythroleukemia and primary human acute myelogenous leukemia cells in vitro. Inhibitors targeting mutant IDH2/R140Q could have potential applications as a differentiation therapy for cancer.

-20°C

51202000